Market news

Rockwell Medical Inc (RMTI) expands gross margins to 18% and reiterates full-year guidance amid strategic West Coast growth.

Moby summary of Rockwell Medical, Inc.'s Q2 2026 earnings call

Motley Fool Press Release.

Rockwell Medical (RMTI) delivered earnings and revenue surprises of -100.00% and -0.34%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Rockwell Medical, Inc., a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced financial and operational results for the three and six months ended June 30, 2026. Net sales for the three months ended June 30, 2026 were $17.8 million, which...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Rockwell Medical (RMTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

WIXOM, Mich., July 22, 2026--Brian Cox joins Rockwell Medical as VP, Quality and Regulatory Compliance, bringing more than 20 years' healthcare experience to the Company.

WIXOM, Mich., July 20, 2026--Rockwell Medical received notice from Nasdaq that it regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2).

WIXOM, Mich., July 16, 2026--Rockwell Medical will release its results for the second quarter ended June 30, 2026 on Thursday, August 13, 2026.